CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2022	Jan. 01, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Consolidated net income	$ 2,022	$ 2,429
Adjustments to reconcile consolidated net income to net cash provided by (used in) operating activities:
Stock-based compensation	79	74
Gain on forgiveness of PPP Loans	(272)	0
Deferred income taxes	9	180
Depreciation and amortization	1,033	1,079
Amortization of operating lease assets	311	153
Amortization of deferred financing costs	12	12
Changes in operating assets and liabilities:
Accounts receivable	(1,003)	104
Inventories	254	(915)
Prepaid, refundable and accrued income taxes	103	121
Prepaid expenses and other current assets	268	1,151
Other assets	10	16
Accounts payable - trade	280	(80)
Accrued expenses and other current liabilities	(3,975)	(462)
Net cash provided by (used in) operating activities	(903)	3,852
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of fixed assets	(797)	(449)
Loans and advances made to employees	(14)	(11)
Payments received on employee receivables	60	52
Net cash used in investing activities	(751)	(408)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on notes payable	(1,257)	(1,919)
Principal payments on PPP Loans	(531)	0
Dividends paid	(450)	0
Distributions to non-controlling interests	(120)	(529)
Net cash used in financing activities	(2,358)	(2,448)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(4,012)	996
CASH AND CASH EQUIVALENTS, Beginning of period	23,439	19,171
CASH AND CASH EQUIVALENTS, End of period	19,427	20,167
Cash paid during the period for:
Interest	416	263
Income taxes	2	8
Certificates of Deposit
Adjustments to reconcile consolidated net income to net cash provided by (used in) operating activities:
Accrued interest on note receivable from NMR	(23)	0
Notes Receivable
Adjustments to reconcile consolidated net income to net cash provided by (used in) operating activities:
Accrued interest on note receivable from NMR	$ (11)	$ (10)